Roth Capital Has Positive Estimate for MGRM FY2028 Earnings

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Free Report) - Investment analysts at Roth Capital upped their FY2028 EPS estimates for Monogram Orthopaedics in a note issued to investors on Thursday, March 13th. Roth Capital analyst J. Wittes now expects that the company will earn $0.09 per share for the year, up from their prior forecast of $0.06. The consensus estimate for Monogram Orthopaedics' current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics' FY2029 earnings at $0.41 EPS.

Separately, Roth Mkm raised their price objective on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a "buy" rating in a research report on Tuesday.

Monogram Orthopaedics Trading Down 6.5 %

Monogram Orthopaedics stock traded down $0.24 during midday trading on Friday, hitting $3.43. 1,824,627 shares of the stock were exchanged, compared to its average volume of 286,007. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90. The stock has a market capitalization of $121.04 million, a price-to-earnings ratio of -7.30 and a beta of 1.66. The stock's 50-day simple moving average is $2.56 and its 200 day simple moving average is $2.49.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Remove Ads

Institutional Investors Weigh In On Monogram Orthopaedics

Hedge funds and other institutional investors have recently bought and sold shares of the company. Jane Street Group LLC acquired a new stake in shares of Monogram Orthopaedics during the fourth quarter valued at about $25,000. Northern Trust Corp increased its position in shares of Monogram Orthopaedics by 110.6% during the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company's stock valued at $109,000 after acquiring an additional 24,088 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Monogram Orthopaedics by 286.6% during the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company's stock valued at $27,000 after acquiring an additional 8,597 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Monogram Orthopaedics by 7.7% during the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company's stock valued at $537,000 after acquiring an additional 16,234 shares during the last quarter. Finally, Orion Portfolio Solutions LLC acquired a new stake in shares of Monogram Orthopaedics during the fourth quarter valued at about $31,000. 0.45% of the stock is currently owned by institutional investors and hedge funds.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.